Status:
WITHDRAWN
Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment
Lead Sponsor:
Hadassah Medical Organization
Conditions:
MS Patient With Relpasing Remitting Attacks
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The study aims to assess the safety and efficacy of nasale administration of Dexamethasone in relapsing MS patients
Eligibility Criteria
Inclusion
- MS patients with esatblished relapsing remitting attacks
- increase in EDSS of at least 1 point for a least one day
Exclusion
- children under 18
- pregnant patients
- patients with diabetes
- known allergy to steroids
- patients who received steroids within 3 months prior to the study
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00674141
Start Date
July 1 2008
End Date
January 1 2009
Last Update
June 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120